Phenolic Compounds May Explain Mediterranean Diet Benefits
Phenolic compounds in olive oil, which have antioxidant, anti-inflammatory and anti-clotting properties, may explain cardiovascular health benefits associated with the so-called Mediterranean Diet, according to a new study.
Drug Interactions Causing Significant Impact on Statin Use
A new study has found that many people who stopped taking cholesterol-lowering statin drugs were also taking an average of three other drugs that interfered with the normal metabolism of the statins.
Research Suggests Vitamin D Supplements Do Not Improve Cholesterol as Previously Thought
Vitamin D has been touted for its positive effects on a range of human systems, from enhancing bone health to reducing the risk of developing certain types of cancer.
Birch Bark Ingredient Comes with Many Metabolic Benefits
An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies that are reported in the January issue of Cell Metabolism.
Omega-3 Levels Better Predictor of Death Risk than Serum Cholesterol
The results of a person's omega 3 levels is a better predictor of death risk than the serum cholesterol tests routinely given to patients by their doctors. Have you had your omega 3 level tested?
Eating Cholesterol-Lowering Foods Results in Bigger Decrease in LDL Than Low-Saturated-Fat Diet
Persons with high cholesterol who received counseling regarding a diet that combined cholesterol-lowering foods such as soy protein, nuts and plant sterols over 6 months experienced a greater reduction in their low-density lipoprotein cholesterol (LDL-C) levels than individuals who received advice on a low-saturated fat diet.
Do Eggs Have a Lipid That Lowers Cholesterol Absorption?
Nutrition researchers at Kansas State University have published the first evidence that the absorption of cholesterol is reduced by another compound in the egg, a lecithin.
Fat in the Liver, Not the Belly, is a Better Marker for Disease Risk
New findings suggest that it's not whether body fat is stored in the belly that affects metabolic risk factors for diabetes, high blood triglycerides and cardiovascular disease, but whether it collects in the liver.
Are Statins Causing Diabetes? Disturbing Link Found.
Patients that were prescribed statins were 87% more likely to develop diabetes, even though they were free of heart disease, diabetes, and other severe...
Statins May Simulate Stem Cells For Heart Repair
The drug pravastatin, which is used widely to decrease high cholesterol, may provide a previously unknown cardiovascular benefit in addition to lowering lipids.
Common Heart Drug’s Link to Diabetes Found by Researchers
Researchers may have found a novel way to suppress the devastating side effect of one of the worlds' most widely used drugs to lower cholesterol and prevent heart disease.
Substance in Tangerines Fights Obesity and Protects Against Heart Disease
New research has discovered a substance in tangerines not only prevents obesity, but also offers protection against type 2 diabetes, and even atherosclerosis.
Study: High Good Cholesterol Trumps Low Bad Cholesterol For Heart Protection
Having a high level of HDL cholesterol – the good cholesterol – is more important than having a low level of LDL – the bad cholesterol.
Scientists Find Protein May Be Key to New Therapies for Elevated Triglycerides
Researchers have identified a potential target for the development of new therapies to treat hypertriglyceridemia, a lipid disorder commonly seen in people who are obese and diabetic.
Exercise, Diet, Supplements Play Role in Lowering Cholesterol without Drugs
When it's time to rein in cholesterol, the go-to prescription is usually statins. These medications can reduce low-density lipoprotein (LDL) cholesterol (the bad cholesterol) from 25 percent to 50 percent, but statins aren't for everyone. The Mayo Clinic Women's HealthSource outlines other ways to lower cholesterol.
Study Identifies Key Factor that Links Metabolic Syndrome
A new study led by researchers at Joslin Diabetes Center has identified insulin resistance in the liver as a key factor in the cause of metabolic syndrome and its associated atherosclerosis.



